Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial.
Malka D, Verret B, Faron M, Guimbaud R, Caramella C, Edeline J, Galais MP, Bengrine-Lefevre L, Smith D, Dupont-Bierre E, De Baere T, Goéré D, Dartigues P, Lacroix L, Boige V, Gelli M, Pignon JP, Ducreux M. Malka D, et al. Among authors: dupont bierre e. Eur J Cancer. 2023 Dec;195:113400. doi: 10.1016/j.ejca.2023.113400. Epub 2023 Oct 28. Eur J Cancer. 2023. PMID: 37922632 Clinical Trial.
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment.
Rigault E, Lacas B, Glehen O, Smith D, Dupont-Bierre E, Guimbaud R, Malka D, Boige V, Fuerea A, Pignon JP, Ducreux M. Rigault E, et al. Among authors: dupont bierre e. Cancer Treat Res Commun. 2023;34:100674. doi: 10.1016/j.ctarc.2022.100674. Epub 2022 Dec 16. Cancer Treat Res Commun. 2023. PMID: 36565566 Free article. Clinical Trial.
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
Boilève A, Maillard A, Wagner M, Dromain C, Laurent C, Dupont Bierre E, Le Sourd S, Audemar F, Ulusakarya A, Guerin-Meyer V, Smisth D, Pezzella V, De Baere T, Goere D, Gelli M, Taieb J, Boige V. Boilève A, et al. Among authors: dupont bierre e. BMC Cancer. 2020 Jan 30;20(1):74. doi: 10.1186/s12885-020-6571-7. BMC Cancer. 2020. PMID: 32000724 Free PMC article. Clinical Trial.
Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pintière C, Daniel P, Genetet N, Meunier B, Dupont-Bierre E, Boudjema K, Catros V. Bouet-Toussaint F, et al. Among authors: dupont bierre e. Cancer Immunol Immunother. 2008 Apr;57(4):531-9. doi: 10.1007/s00262-007-0391-3. Epub 2007 Sep 1. Cancer Immunol Immunother. 2008. PMID: 17764010 Free PMC article.
C4d: a marker for hepatic transplant rejection.
Lorho R, Turlin B, Aqodad N, Triki N, de Lajarte-Thirouard AS, Camus C, Lakehal M, Compagnon P, Dupont-Bierre E, Meunier B, Boudjema K, Messner M. Lorho R, et al. Among authors: dupont bierre e. Transplant Proc. 2006 Sep;38(7):2333-4. doi: 10.1016/j.transproceed.2006.06.120. Transplant Proc. 2006. PMID: 16980082
[Liver transplantation for hepatocellular carcinoma].
Boudjema K, Compagnon P, Dupont-Bierre E, Lorho R, Lakehal M, Thirouard AS, Meunier B, Messner M. Boudjema K, et al. Among authors: dupont bierre e. Cancer Radiother. 2005 Nov;9(6-7):458-63. doi: 10.1016/j.canrad.2005.09.009. Epub 2005 Oct 11. Cancer Radiother. 2005. PMID: 16223596 Free article. French.
[Two tapes to control the main fissure of the liver].
Boudjema K, Veilhan LA, Dupont-Bierre E, Lakehal M. Boudjema K, et al. Among authors: dupont bierre e. Ann Chir. 2002 Feb;127(2):149-53. doi: 10.1016/s0003-3944(01)00692-7. Ann Chir. 2002. PMID: 11885377 French.
12 results